CHMP positives for AbbVie, AstraZeneca, J&J drugs
This article was originally published in Scrip
Executive Summary
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended for approval AbbVie's Cholib (fenofibrate/simvastatin), AstraZeneca's Nexium Control (esomeprazole), and Johnson & Johnson's Omrix Biopharmaceuticals' Evarrest (human fibrinogen/human thrombin).